Atraverse Medical, a San Diego, CA-based medical device company, raised $12.5M in Seed funding.
This financing included investment from physicians, reputable venture investors, and successful medtech entrepreneurs.
The company intends to use the funds to expand its research and development efforts as well as early commercialization initiatives.
Led by CEO John Slump, Atraverse Medical announced the FDA clearance of its HOTWIRE™ radiofrequency (RF) guidewire, a novel device invented by Atraverse Co-Founders Dr. Steven Mickelsen and Eric Sauter that enables zero exchange left-heart access while also acting as a rail for catheter-based therapy systems. This milestone achievement marks a significant step towards commercializing the company’s left-heart access technology.
FinSMEs
17/05/2024